ALFA FinderNSE filing, NSE: BALPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Bal Pharma Ltd: key numbers
- Share price
- ₹81.55
- Market cap
- ₹129.8 Cr
- Revenue (annual)
- ₹311.7 Cr
- Net profit (annual)
- ₹6.28 Cr
- P/E (TTM)
- 18.0×Sector 43.0×
- Promoter holding
- 50.86%+0.00% QoQ
- FII holding
- 0.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bal Pharma Ltd
All →Bal Pharma Board Meeting Date
Bal Pharma Limited informs exchanges of a board meeting on November 11, 2026, to consider unaudited standalone and consolidated results for Q2 FY2026-27. This is a prior intimation with no results figures attached yet.
Bal Pharma Other Announcement
Bal Pharma Ltd has filed its quarterly shareholding pattern as mandated under Regulation 31(1)(b) of the SEBI Listing Regulations.
Bal Pharma Dividend
Bal Pharma disbursed its FY25-26 final dividend of ₹1.20 per share on October 9, 2026. Dividends for shareholders with incomplete KYC or bank details have been withheld.
Bal Pharma Management Change
Bal Pharma Limited announced a change in designations for directors Ravindra Kumar Kothari and Virupakshaya Himesh, effective October 1, 2026.
Bal Pharma Annual General Meeting
Bal Pharma Ltd held its 39th Annual General Meeting on September 24, 2026, where shareholders transacted all business items as per the notice.
Bal Pharma Price Movement Clarification
Bal Pharma has clarified that the recent significant movement in its share price is purely market-driven and not due to any undisclosed price-sensitive information.
Other merger & restructuring announcements
All →AAA Technologies Merger & Restructuring
AAA Technologies approved four wholly owned subsidiaries in Singapore, Mauritius, Dubai and India. Each entity is in IT security, cybersecurity and technology services.
Tirupati Starch & Chemicals Merger & Restructuring Worth ₹2.98 Cr
Tirupati Starch agreed to sell its Indore immovable property to Usha and Arpit Doshi for Rs 2.98 Crore. Completion is expected by 15 January 2027, subject to conditions.
- Value
- ₹2.98 Cr
- Execution
- Completion expected on or before 15 January 2027
CFF Fluid Control Merger & Restructuring
CFF Fluid Control will form a 51% joint venture with TKMS Atlas Elektronik for anti-submarine warfare in India. No deal value is disclosed.
Trom Industries Merger & Restructuring Worth ₹0.02 Cr
Trom Industries plans to incorporate Trom Energy SPV Private Limited, a solar power subsidiary, holding 98%. The initial cash subscription is Rs 1,96,000 for 19,600 shares.
- Value
- ₹0.02 Cr
Yasons Chemex Care Merger & Restructuring Worth ₹29.61 Cr
Yasons Chemex's subsidiary Rishit Polysurf LLP signed a slump sale agreement to sell its chemical manufacturing business to Vasudha Specialities Emulsifiers. Consideration is Rs.29.61 Crore in cash.
- Value
- ₹29.61 Cr
Dhruv Consultancy Services Merger & Restructuring Worth ₹0.3 Cr
Dhruv Consultancy incorporated Valsang Drivehub Private Limited, subscribing to 55% for Rs.0.30 Crore. The subsidiary will execute a wayside amenities project under an NHLML award.
- Value
- ₹0.30 Cr